Reuters: Healthcare

UPDATE 1-J&J plans filing on more than 10 new drugs by 2017

Thu, 23 May 2013 12:30:42 GMT

May 23 (Reuters) - Johnson & Johnson said on Thursday it plans to submit more than 10 new products for regulatory approval by 2017, including drugs to treat hepatitis C, immune diseases and schizophrenia, and vaccines for flu, rabies and polio.

REFILE-Saudi Arabia confirms another death from SARS-like virus

Thu, 23 May 2013 12:10:43 GMT

DUBAI, May 23 (Reuters) - Saudi Arabia has announced another death from the SARS-like novel coronavirus (nCoV) in its central al-Qassim region, bringing the total number of deaths in the kingdom to 17.

UPDATE 1-BTG says interventional medicine buys could boost sales to $1 bln

Thu, 23 May 2013 12:05:13 GMT

* Buys EKOS Corp, Nordion unit for combined initial $380 mln

UPDATE 1-Royalty cuts acceptance bar for Elan bid to 50 pct

Thu, 23 May 2013 12:00:20 GMT

* Royalty cuts acceptance threshold from 90 pct previously

Johnson & Johnson plans on more than 10 drugs filed by 2017

Thu, 23 May 2013 11:56:34 GMT

May 23 (Reuters) - Johnson & Johnson said on Thursday that it plans to submit more than 10 new products for regulatory approval by 2017, including drugs to treat hepatitis C, immune diseases, and schizophrenia as well as vaccines for flu, rabies and polio.

Wockhardt says FDA alert affects potential sales of $100 mln

Thu, 23 May 2013 11:32:06 GMT

MUMBAI, May 23 (Reuters) - Indian drug maker Wockhardt Ltd said up to $100 million in annualised revenue could be lost as a result of a U.S. Food and Drug Administration "import alert" on one of its plants, but said it should be able to restore most of that within 6 to 9 months by shifting production elsewhere.

RPT-FEATURE-Pfizer takes its shot at a vaccine for evasive superbug

Thu, 23 May 2013 10:59:58 GMT

CHICAGO, May 23 (Reuters) - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year pneumonia and meningitis vaccine Prevnar 13 for Pfizer.

DEALTALK-Hospital firms say research tie-ups can clinch takeovers

Thu, 23 May 2013 10:59:58 GMT

NEW YORK, May 23 (Reuters) - Hospital companies that tie up with top medical research facilities to improve their access to the latest treatments and bolster their reputations are increasingly finding the partnerships also make it easier for them to do takeovers.

GSK flu shot may raise adult narcolepsy risk -Finnish scientists

Thu, 23 May 2013 10:52:08 GMT

HELSINKI/LONDON, May 23 (Reuters) - GlaxoSmithKline Plc's H1N1 pandemic flu shot may put adults at higher risk of developing narcolepsy, not only children as previous studies found, Finland's National Institute for Health and Welfare said on Thursday.

BRIEF-Royalty Pharma updates terms of Elan offer

Thu, 23 May 2013 10:37:36 GMT

LONDON, May 23 (Reuters) - Royalty Pharma : * Royalty Pharma reduces acceptance condition to 50% plus one share * Under the terms of the increased offer, Royalty Pharma is offering to acquire Elan for $12.50 per share in cash * Increased offer represents a value of $4.6 billion for Elan's Tysabri royalty * Offer is fully financed and is not conditional on due

Malaysia IHH's Q1 net profit up 3.67 pct

Thu, 23 May 2013 10:15:39 GMT

KUALA LUMPUR, May 23 (Reuters) - Malaysia's IHH Healthcare Bhd, the world's second-largest listed private healthcare provider by market value, posted a 3.67 percent rise in first-quarter profit, driven by core earnings growth and lower finance costs.

Deals of the day -- mergers and acquisitions

Thu, 23 May 2013 10:08:12 GMT

May 23 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1000 GMT on Thursday:

India sets guidelines to meet EU drug import rules

Thu, 23 May 2013 07:25:13 GMT

May 23 (Reuters) - The Indian government said on Thursday it had set guidelines for pharmaceutical makers to comply with a European Union directive on standards for import of bulk drugs into the EU that takes effect on July 2.

BRIEF-Shares in Aixtron fall 3.1 pct after job cuts plan

Thu, 23 May 2013 07:07:36 GMT

FRANKFURT, May 23 (Reuters) - * Shares in Aixtron SE fall 3.1 percent after it announces job cuts

BTG builds interventional medicine platform with deals

Thu, 23 May 2013 07:00:59 GMT

LONDON, May 23 (Reuters) - Britain's BTG said it would make two acquisitions, one extending its expertise in liver cancer and the other a treatment for severe blood clots, to create an interventional medicine business with potential sales of $1 billion.

BRIEF-BTG to buy targeted therapies arm of Nordion

Thu, 23 May 2013 06:14:18 GMT

LONDON, May 23 (Reuters) - BTG PLC : * Proposed acquisition of therasphere * To buy the targeted therapies division of nordion, for approximately US$200

BRIEF-BTG to buy blood clot treatment specialist EKOS

Thu, 23 May 2013 06:12:30 GMT

LONDON, May 23 (Reuters) - BTG PLC : * Acquisition of ekos * Has entered into an agreement to buy ekos corporation for an initial cash of

FEATURE-Pfizer takes its shot at a vaccine for evasive superbug

Thu, 23 May 2013 04:59:58 GMT

Nebraska attorney general wants abortion clinic nurse's license revoked

Thu, 23 May 2013 03:42:34 GMT

OMAHA, Neb., May 22 (Reuters) - Nebraska Attorney General Jon Bruning on Wednesday filed a petition to revoke the license of the only nurse at a controversial abortion clinic in the state for allegedly providing substandard care and improperly administering drugs.

UPDATE 2-Merck's insomnia drug moves a step closer to U.S. approval

Thu, 23 May 2013 00:48:13 GMT

* FDA panel says suvorexant safe, effective at lower doses

Singapore Stocks - Factors to watch on May 23

Thu, 23 May 2013 00:40:36 GMT

SINGAPORE, May 23 (Reuters) - Following is some company-related and market news which could have an impact on the local market. ----------------------MARKET SNAPSHOT @ 0029 GMT ------------ INSTRUMENT LAST PCT CHG NET CHG S&P 500 1655.35 -0.83% -13.810 USD/JPY 103.43 0.27% 0.280 10-YR US TSY YLD 2.0651 --

UPDATE 1-FDA panel says Merck's sleep drug safe, effective at lower dose

Wed, 22 May 2013 22:53:19 GMT

WASHINGTON, May 22 (Reuters) - Merck & Co's experimental insomnia drug was safe and effective at the lower of two doses studied, a panel of medical experts said on Wednesday, increasing the chance it will be approved by the U.S. Food and Drug Administration.

U.S. Senate committee advances drug compounding bill

Wed, 22 May 2013 22:41:16 GMT

NEW YORK, May 22 (Reuters) - A U.S. Senate committee on Wednesday unanimously approved legislation that would increase federal oversight for companies that compound and sell sterile drugs across state lines.

Shares in NZ's F&P Healthcare jump after record profit

Wed, 22 May 2013 22:09:48 GMT

WELLINGTON, May 23 (Reuters) - Shares in New Zealand's Fisher & Paykel Healthcare Ltd jumped to a two-year high on Thursday, after the medical equipment manufacturer reported record full-year profits and forecast an even brighter 2014.

NZ's F&P Healthcare FY profit hits record high on strong demand

Wed, 22 May 2013 21:17:29 GMT

WELLINGTON, May 23 (Reuters) - New Zealand medical equipment manufacturer Fisher & Paykel Healthcare Ltd. reported a 20 percent rise in full-year net profit on Thursday, on higher sales and improved margins, and said it saw profits increasing in the current year.